DK0877750T3 - Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner - Google Patents

Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner

Info

Publication number
DK0877750T3
DK0877750T3 DK96937702T DK96937702T DK0877750T3 DK 0877750 T3 DK0877750 T3 DK 0877750T3 DK 96937702 T DK96937702 T DK 96937702T DK 96937702 T DK96937702 T DK 96937702T DK 0877750 T3 DK0877750 T3 DK 0877750T3
Authority
DK
Denmark
Prior art keywords
hypogolesterolemic
azetidinones
sugar
substituted
agents
Prior art date
Application number
DK96937702T
Other languages
Danish (da)
English (en)
Inventor
Nathan P Yumibe
Kevin B Alton
Heek Margaret Van
Harry R Davis
Wayne D Vaccaro
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26677904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0877750(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0877750T3 publication Critical patent/DK0877750T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK96937702T 1995-10-31 1996-10-29 Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner DK0877750T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US818595P 1995-10-31 1995-10-31
US60818595A 1995-10-31 1995-10-31
US57084795A 1995-12-12 1995-12-12
PCT/US1996/016823 WO1997016455A1 (en) 1995-10-31 1996-10-29 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents

Publications (1)

Publication Number Publication Date
DK0877750T3 true DK0877750T3 (da) 2002-07-15

Family

ID=26677904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96937702T DK0877750T3 (da) 1995-10-31 1996-10-29 Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner

Country Status (28)

Country Link
EP (1) EP0877750B1 (zh)
JP (2) JP3385031B2 (zh)
KR (1) KR100311554B1 (zh)
CN (1) CN1103780C (zh)
AR (1) AR004701A1 (zh)
AT (1) ATE219495T1 (zh)
AU (1) AU712158B2 (zh)
BR (2) BR9612998B1 (zh)
CA (1) CA2235943C (zh)
CY (1) CY2353B1 (zh)
CZ (1) CZ293957B6 (zh)
DE (1) DE69621952T2 (zh)
DK (1) DK0877750T3 (zh)
ES (1) ES2175141T3 (zh)
GE (1) GEP20033006B (zh)
HK (1) HK1012507A1 (zh)
HU (1) HU226822B1 (zh)
ID (1) ID16177A (zh)
IL (1) IL124268A (zh)
MX (1) MX9803447A (zh)
MY (1) MY114803A (zh)
NO (1) NO311692B1 (zh)
NZ (1) NZ321766A (zh)
PL (1) PL184698B1 (zh)
PT (1) PT877750E (zh)
SK (1) SK283552B6 (zh)
TW (1) TW448181B (zh)
WO (1) WO1997016455A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
HUP0302269A3 (en) * 2000-12-20 2009-08-28 Schering Corp Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
EP1510521A1 (en) * 2000-12-20 2005-03-02 Schering Corporation Sugar-substituted 2-Azetidinones useful as hypocholesterolemic agents
ATE349425T1 (de) 2000-12-21 2007-01-15 Sanofi Aventis Deutschland Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
CA2434430A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis The use of substituted azetidinone compounds for the treatment of sitosterolemia
AU2005246926B2 (en) * 2001-01-26 2008-02-28 Merck Sharp & Dohme Corp. The use of substituted azetidinone compounds for the treatment of sitosterolemia
US20020147184A1 (en) * 2001-01-26 2002-10-10 Schering Corporation Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
BRPI0208384B1 (pt) 2001-03-28 2016-05-31 Merck Sharp & Dohme síntese enantiosseletiva de compostos intermediários de azetidinona
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
US7176194B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176193B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
DE10227506A1 (de) * 2002-06-19 2004-01-08 Aventis Pharma Deutschland Gmbh Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US7671047B2 (en) 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
AR041089A1 (es) 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
JP2005015434A (ja) 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (en) 2003-10-07 2005-04-13 Lipideon Biotechnology AG Novel hypocholesterolemic compounds
EP1682117A1 (en) * 2003-10-30 2006-07-26 Merck & Co., Inc. 2-azetidinones as anti-hypercholesterolemic agents
SA04250427A (ar) 2003-12-23 2005-12-03 استرازينيكا ايه بي مشتقات ثاني فينيل أزيتيدون
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
WO2006116499A1 (en) * 2005-04-26 2006-11-02 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-one glucuronide derivatives for hypercholesterolemia
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AU2006304836A1 (en) 2005-10-21 2007-04-26 Novartis Ag Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20080319221A1 (en) 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007063671A1 (de) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CA2754384A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
CN103102297A (zh) * 2012-09-28 2013-05-15 北京赛林泰医药技术有限公司 一种新的依折麦布的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
CA2120221A1 (en) * 1993-04-23 1994-10-24 Allan W. Rey N-substituted 2-azetidinones
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
MX9803447A (es) 1998-09-30
MY114803A (en) 2003-01-31
PL184698B1 (pl) 2002-12-31
NO981950D0 (no) 1998-04-29
CA2235943A1 (en) 1997-05-09
BR9612998B1 (pt) 2010-03-23
HUP9802539A2 (hu) 1998-11-30
AR004701A1 (es) 1999-03-10
GEP20033006B (en) 2003-07-10
SK283552B6 (sk) 2003-09-11
SK48398A3 (en) 1998-11-04
IL124268A (en) 2005-08-31
CY2353B1 (en) 2004-06-04
TW448181B (en) 2001-08-01
CN1103780C (zh) 2003-03-26
CZ293957B6 (cs) 2004-08-18
HK1012507A1 (en) 1999-08-06
CZ129498A3 (cs) 1998-10-14
DE69621952T2 (de) 2003-01-16
AU712158B2 (en) 1999-10-28
AU7517996A (en) 1997-05-22
NO981950L (no) 1998-06-26
BR9611401B1 (pt) 2010-08-10
JPH10512592A (ja) 1998-12-02
HU226822B1 (en) 2009-11-30
HUP9802539A3 (en) 1999-12-28
ID16177A (id) 1997-09-11
CA2235943C (en) 2002-10-01
ES2175141T3 (es) 2002-11-16
KR100311554B1 (ko) 2002-06-20
CN1205707A (zh) 1999-01-20
WO1997016455A1 (en) 1997-05-09
JP2001048895A (ja) 2001-02-20
NZ321766A (en) 1999-07-29
EP0877750B1 (en) 2002-06-19
DE69621952D1 (de) 2002-07-25
NO311692B1 (no) 2002-01-07
ATE219495T1 (de) 2002-07-15
PL327987A1 (en) 1999-01-04
KR19990067202A (ko) 1999-08-16
PT877750E (pt) 2002-09-30
JP3385031B2 (ja) 2003-03-10
BR9611401A (pt) 1999-01-05
EP0877750A1 (en) 1998-11-18

Similar Documents

Publication Publication Date Title
DK0877750T3 (da) Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner
DE69636353D1 (de) Datenübetragungsvorrichtung.
NL1004863A1 (nl) 5-Amino-4-ethylsulfinyl-1-arylpyrazolen.
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
NO960499D0 (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
ES1032571Y (es) Gafa,
NL1002934C2 (nl) Deur.
FI954956A0 (fi) Taecklist foer foensterkarmar, till skydd deras ytteryta
FI950956A0 (fi) Luftkabel, saosom haengspiralkabel
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
ITTO950598A0 (it) Via tranviaria.
TR199501236A2 (tr) Halka bicimindeki birarada tutma vasitasi.
ES1032458Y (es) Estrctura porta-bidones.
ES1030500Y (es) Braga-compresa monouso.
IT1282308B1 (it) Portaguinzagli.
ES1031132Y (es) Prensa-latas.
ES1032568Y (es) Protector-precinto.
ES1032636Y (es) Osario.
ES1029950Y (es) Interruptor-conmutador.
ES1030124Y (es) Bloc-pizarra.
ES1032657Y (es) Banderilla.
ES1033612Y (es) Octocarton.